Format: 1-hour Virtual Thought Leadership Session
Date & Time: Tuesday, 7th October 2025, 1:30–2:30 PM BST / 8:30–9:30 AM EST
Platform: Zoom
1:30 PM – Thought Leader Interview (20 mins)
Interview with: Aline F. Miller, Professor of Biomolecular Engineering, Chief Scientific Officer of Unit M at the University of Manchester
2:00 PM – Panel Discussion (30 mins)
Panel Discussion Title: Advancing Drug Discovery: Animal-Free Innovation in Organoids & 3D Cell Culture
- Redefining the Matrix: Replacing animal-derived scaffolds with synthetic, peptide-based hydrogels for reproducible, ethical organoid culture.
- From Serum to Standards: Transitioning to chemically defined, xeno-free reagents to enhance translational relevance and regulatory compliance.
- Towards Scalable Biology: Enabling industrialization of organoid systems through animal-free 3D biofabrication and quality-controlled workflows
Moderator:
Professor Aline F. Miller, Professor of Biomolecular Engineering, Chief Scientific Officer of Unit M, University of Manchester
Panellists:
Maryna Panamarova, Cellular Modelling Specialist, Cellular Operations, Wellcome Sanger Institute, Wellcome Genome Campus
Vasiliki Kalodimou, Assistant Professor Dr/Director Flow Cytometry-Research & Regenerative Medicine,, EUC Frankfurt Branch
Andy Wiranata Wijaya, BioProcess Development Lead, Nestle
To attend this Thought Leadership session you need to be a Premium LifeScienceXchange member.
Secure all the benefits and sign-up for Premium membership now
*If you’re already a Premium member your exclusive invite will be sent direct to your inbox